APOPTOTIC RESPONSE OF OVARIAN CANCER CELLS IN HYPOXIC CONDITIONS
Claus Poulsen, Bryan Lincoln, Ivan P. Dimov, José L. García-Cordero, Marek W. Radomski, Luke P. Lee
Abstract
Claus Poulsen, Bryan Lincoln, Ivan P. Dimov, José L. García-Cordero, Marek W. Radomski, Luke P. Lee
Abstract
A cell culture device is presented that has a daily consumption of only 20 μl media. The device is used for testing the response of ovarian cancer cells to the chemotherapy drug Paclitaxel at hypoxic conditions. In hypoxic conditions, the mortality is increased 3.2 times at 34 μg/ml Paclitaxel. However, this might not be due to apoptosis as the mitochondria activity and nuclei size is unchanged compared to in the absence of Paclitaxel.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A cell culture device is presented that has a daily consumption of only 20 μl media. The device is used for testing the response of ovarian cancer cells to the chemotherapy drug Paclitaxel at hypoxic conditions. In hypoxic conditions, the mortality is increased 3.2 times at 34 μg/ml Paclitaxel. However, this might not be due to apoptosis as the mitochondria activity and nuclei size is unchanged compared to in the absence of Paclitaxel.
Key concepts: Paclitaxel, Apoptosis, Ovarian cancer, Chemotherapy, Cancer research, Cancer cell, Drug response, Biology